ATZREMEG INJECTION contains Aztreonam, a monobactam antibiotic with activity against susceptible Gram-negative aerobic bacteria. It works by interfering with bacterial cell-wall synthesis and may be used for the management of certain bacterial infections when appropriate antibiotic therapy is required.
Aztreonam may be administered by intravenous (IV) or intramuscular (IM) injection, depending on the prescribed treatment and clinical condition. It is commonly used in hospital and clinical settings for susceptible bacterial infections, including infections caused by organisms such as Pseudomonas aeruginosa.
Composition:
- Aztreonam – Injection
- Exact strength: Not provided; use the approved product label for the strength.
Indications / Uses
- Certain lower respiratory tract infections
- Urinary tract infections (UTIs)
- Septicemia and other bloodstream infections
- Certain intra-abdominal infections
- Skin and soft tissue infections
- Other susceptible Gram-negative bacterial infections as prescribed
Key Benefits
- Effective against susceptible Gram-negative aerobic bacteria
- Active against certain strains of Pseudomonas aeruginosa
- Available for IV and IM administration
- Provides targeted antibacterial activity
- Suitable for hospital and clinical use when medically indicated
Important: ATZREMEG INJECTION is a prescription antibiotic and should be administered only under the direction of a qualified healthcare professional. Antibiotic selection should be based on the suspected or confirmed bacterial infection and susceptibility where appropriate. It should not be used for viral infections.
